Apixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
During extended treatment, bleeding risk was similar for apixaban and rivaroxaban.
Diagnosis & Disease Information
Predictors of VTE Risk Identified in Patients With Thrombophilia and Cancer
Researchers sought to determine risk factors for developing VTE among patients with thrombophilia and cancer who were receiving chemotherapy.
Lower Risk of Recurrent VTE With Direct Oral Anticoagulants vs Warfarin During Extended Anticoagulation
Researchers sought to determine whether direct oral anticoagulant or warfarin would be better for recurrent VTE in patients taking extended anticoagulation treatment.
Healthcare Utilization, Costs, Mortality High With Thromboembolic Events in Polycythemia Vera
Researchers sought to determine the healthcare resource utilization, costs, and mortality associated with patients with polycythemia vera who had thromboembolic events.
Predictive Tools for Thrombosis Recurrence in Antiphospholipid Syndrome Demonstrate Suboptimal Performance
Investigators aimed to validate the performance of 3 different models for the prediction of thrombosis recurrence among patients with antiphospholipid syndrome.
Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
Findings seen among adults prescribed warfarin, DOACs beyond six months after acute venous thromboembolism.
Carfilzomib May Not Increase Risk of VTE in MM, According to a Retrospective Study
Researchers sought to determine whether carfilzomib with lenalidomide and dexamethasone would increase risk of VTE in patients with MM compared with bortezomib plus lenalidomide and dexamethasone.
Characteristics Identified for VTE in Young Adults, Older Adults, and Adolescents
Researchers sought to determine the different characteristics for acute VTE in young adults and older adults.
VTE Not Associated With All-Cause Mortality in Patients With PNH
Researchers sought to determine whether VTE would be associated with higher all-cause mortality in patients with PNH.
Direct Oral Anticoagulant Therapy Noninferior to LMWH in Preventing Recurrent VTE in Patients With Cancer
Researchers sought to determine whether direct oral anticoagulants would do as well in preventing VTE in patients with cancer as LMW heparin
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...